ReviewCells2026

Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives.

Hiroshi Yasui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.